Evolent Health (NYSE: EVH) reported Q4 EPS of ($0.05), $0.16 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $46.1 million versus the consensus estimate of $43.73 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.